Earnings History Data for NuCana (NCNA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
NuCana
NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company's pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in EDINBURGH, United Kingdom.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25-11-2024 | PM | NCNA | NuCana | 3.00 | -2.28 | -3.49 | 0.00 | NuCana GAAP EPS of -£0.07 [11/25/2024 7:16 AM] |
1.26 | 0.03 (2.44%) |
1.34 | 0.11 (8.81%) |
1.23 - 19.41 | 193,151 | 150,000 | 65,313 | ||
| 15-08-2024 | AH | NCNA | NuCana | 9.00 | -3.79 | -3.55 | 0.00 | NuCana GAAP EPS of -£0.12 [8/15/2024 4:57 PM] |
3.50 | 0.21 (6.38%) |
3.44 | 0.15 (4.56%) |
2.53 - 20.25 | 21,745 | 10,000 | 377 | ||
| 20-03-2024 | AH | NCNA | NuCana | 19.00 | -0.17 | -0.13 | 0.00 | NuCana GAAP EPS of -£0.14 [3/20/2024 5:00 PM] |
0.2912 | -0.04 (-12.47%) |
0.33 | -0.01 (-1.98%) |
0.23 - 1.75 | 870,842 | 9,120,000 | 69,524 | ||
| 17-05-2023 | AH | 4:00 PM ET (May 17) |
NCNA | NuCana | 41.00 | -0.18 | -0.12 | 0.00 | NuCana GAAP EPS of -£0.15 [5/17/2023 4:36 PM] |
0.74 | -0.02 (-2.59%) |
0.75 | -0.01 (-1.32%) |
0.57 - 2.24 | 35,942 | 30,000 | 1,200 | |
| 16-11-2022 | AH | 4:00 PM ET (Nov 16) |
NCNA | NuCana | 53.00 | -0.11 | -0.13 | 0.00 | NuCana GAAP EPS of -£0.09 [11/16/2022 5:13 PM] |
0.99 | -0.07 (-6.60%) |
0.0 | 0.0 (0.00%) |
0.52 - 3.32 | 75,438 | 40,000 | 0 | |
| 17-08-2022 | AH | NCNA | NuCana | 85.00 | -0.09 | -0.14 | 0.00 | NuCana GAAP EPS of -£0.07 [8/17/2022 4:54 PM] |
1.55 | -0.07 (-4.32%) |
1.50 | -0.12 (-7.41%) |
0.52 - 3.32 | 159,011 | 140,000 | 2,132 | ||
| 27-04-2022 | AH | 4:00 PM ET (Apr 27) |
NCNA | NuCana | 44.00 | -0.35 | -0.23 | 0.00 | NuCana GAAP EPS of -£0.26 [4/27/2022 5:32 PM] |
0.74 | 0.0 (0.15%) |
0.75 | 0.01 (1.23%) |
0.69 - 4.62 | 74,721 | 270,000 | 2,336 | |
| 19-08-2021 | AH | NCNA | NuCana plc | 109.02 | -0.24 | -0.24 | -0.24 | NuCana reports Q2 results [8/19/2021 4:15 PM] |
1.93 | -0.02 (-1.03%) |
1.93 | -0.02 (-1.03%) |
1.88 - 7.83 | 189,500 | 310,000 | 3,706 | ||
| 19-05-2021 | AH | 4:00 PM ET (May 19) |
NCNA | NuCana plc | 149.94 | -0.26 | -0.22 | -0.15 | NuCana reports Q1 results [5/19/2021 4:29 PM] |
3.01 | 0.04 (1.35%) |
3.05 | 0.08 (2.69%) |
2.80 - 7.83 | 261,861 | 370,000 | 460 | |
| 19-05-2020 | AH | NCNA | NuCana plc | 179.28 | -0.15 | -0.22 | -0.22 | NuCana EPS beats by £0.07 [5/19/2020 4:16 PM] |
7.37 | 1.56 (26.85%) |
5.90 | 0.09 (1.55%) |
3.81 - 16.00 | 141,924 | 50,876 | 258 | ||
|
|
||||||||||||||||||